Alexandre Grassin

Corporate Officer/Principal at

Calliditas Therapeutics Suisse SA

48 year

Health Technology

Commercial Services

Profile

Alexandre Grassin is currently a Director at Calliditas Therapeutics Suisse SA. Previously, he worked as a Principal at Novartis AG from 2007 to 2010.
He also served as a Financial Auditor at KPMG SA. From 2010 to 2012, he was a Principal at Alexion Pharma GmbH.
Additionally, he held the position of Vice President-Finance & Administration at Calliditas Therapeutics France SAS. Mr. Grassin's most recent former position was as the Chief Financial Officer at enGene Holdings, Inc. in 2023.

Alexandre Grassin active positions

Companies	Position	Start
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes	Corporate Officer/Principal	-

All active positions of Alexandre Grassin

Former positions of Alexandre Grassin

Companies	Position	End
ENGENE THERAPEUTICS INC.	Director of Finance/CFO	2023-11-28
Alexion Pharma GmbH Alexion Pharma GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders	Corporate Officer/Principal	2011-12-31
NOVARTIS AG	Corporate Officer/Principal	2009-12-31
GENKYOTEX SA.	Director of Finance/CFO	-
KPMG SA KPMG SA Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and strategic advisory services	Corporate Officer/Principal	-

See the detail of Alexandre Grassin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexandre Grassin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
KPMG SA KPMG SA Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and strategic advisory services	Commercial Services
Alexion Pharma GmbH Alexion Pharma GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders	Health Technology
Calliditas Therapeutics France SAS Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development	Commercial Services
enGene Holdings, Inc. enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines	Commercial Services